论文部分内容阅读
目的:分析慢性阻塞性肺疾病合并呼吸衰竭患者应用无创通气联合信必可治疗的效果。方法:抽选2012年1月-2015年1月,我院接收慢性阻塞性肺疾病合并呼吸衰竭患者80例,按入院编号分成两组(实验组、对照组),对照组患者给予信必可治疗,实验组患者在该基础上加用无创通气治疗,比对两组患者治疗效果。结果:实验组患者临床治疗好转率和对照组相比,差异性明显(P<0.05)。结论:借助无创通气联合信必可治疗慢性阻塞性肺疾病合并呼吸衰竭患者,安全性高,可改善患者临床症状,提高好转率,值得使用。
OBJECTIVE: To analyze the effect of noninvasive ventilation and Xinbibi in patients with chronic obstructive pulmonary disease and respiratory failure. Methods: From January 2012 to January 2015, 80 patients with chronic obstructive pulmonary disease and respiratory failure in our hospital were divided into two groups (experimental group and control group) according to hospital admission number. Patients in control group Treatment, experimental group patients on the basis of non-invasive ventilation plus treatment, compared with two groups of patients with treatment. Results: The improvement rate of clinical treatment in experimental group was significantly higher than that in control group (P <0.05). Conclusion: With non-invasive ventilation combined with the letter will be the treatment of chronic obstructive pulmonary disease patients with respiratory failure, high safety, can improve clinical symptoms and improve the turnover rate, it is worth using.